# Boston Scientific Corporation (BSX) — Q2-2018 Earnings Results

**Report date:** 2018-07-25 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2018

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 2.23%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.41 | N/A | +16.39% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's growth trajectory. They emphasized their commitment to enhancing product offerings.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They noted ongoing investments in innovation and market expansion.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.23% increase in stock price. The strong EPS performance indicates effective cost management and possibly robust demand for their products. However, the lack of revenue figures and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2018_